NCT02478502 Testis CAB: Cabazitaxel as Salvage Treatment for Cisplatin-resistant Germ Cell Cancer Status TERMINATED Phase PHASE2
NCT02476006 Safety, Tolerability, and Effect of Alirocumab in High Cardiovascular Risk Patients With Severe Hypercholesterolemia Not Adequately Controlled With Conventional Lipid-modifying Therapies (ODYSSEY APPRISE) Status COMPLETED Phase PHASE3
NCT02469116 Carboplatin Plus Docetaxel With Day 2 Pegylated G-CSF (Neulasta®) in Patients With Advanced Stage Ovarian Carcinoma Status TERMINATED Phase PHASE2
NCT02459899 Dose-ranging Study in Patients With Type 1 Diabetes Mellitus Status COMPLETED Phase PHASE2
NCT02451137 A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo (ACHIEVE CONTROL REAL LIFE STUDY PROGRAM) Status COMPLETED Phase PHASE4
NCT02445508 Effect of Bile Acid Secretion and Sequestration on GLP-1 Secretion Status COMPLETED Phase NA
NCT02441894 Combination of Cabazitaxel With Prednisolone With Primary Prophylaxis With PEG-G-CSF in Treatment of Patients With Prostate Cancer Status COMPLETED Phase PHASE4
NCT02440555 Evaluation of the Targeted Screening of Type 2 Diabetes by Capillary Blood Glucose Status COMPLETED Phase N/A
NCT02435121 A Study Assessing Efficacy and Safety of SAR125844 in NSCLC Patients With MET Amplification Status COMPLETED Phase PHASE2
NCT02425904 Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis and LCH-related Disorders Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02421510 Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy Status COMPLETED Phase PHASE3
NCT02414854 Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest) Status COMPLETED Phase PHASE3
NCT02411825 Multiple Ascending Dose Study in Healthy Male Subjects and Overweight to Obese Male and Female Type 2 Diabetes Mellitus (T2DM) Patients Status COMPLETED Phase PHASE1
NCT02407756 A Study to Determine the Safety and Tolerability of Dupilumab (REGN668/SAR231893) in Patients Aged ≥6 to <18 Years With Atopic Dermatitis (Eczema) Status COMPLETED Phase PHASE2
NCT02404558 Single-dose Study to Describe the Safety of Sarilumab and Tocilizumab in Patients With Rheumatoid Arthritis Status COMPLETED Phase PHASE1
NCT02403544 Phase I Study of Image-Guided Radiation Concurrent With Double-Agent Chemotherapy for Hepatocellular Carcinoma Status UNKNOWN Phase PHASE1
NCT02401243 Study of Two Titration Algorithms With Insulin Glargine 300 Units/mL in Type 2 Diabetes Mellitus Patients Status COMPLETED Phase PHASE3
NCT02401191 A Study Assessing the Safety and Effectiveness of FEX60/PE10 Fixed Combination Tablet in Patients With Allergic Rhinitis Status COMPLETED Phase PHASE3
NCT02395237 COMPOUND (INN): HOE490O - GLIMEPIRIDE / METFORMIN HCl (Amaryl® M)0 (Glimepiride/Metformin Hydrochloride Immediate Release Combination Tablet) in Fed Conditions in Healthy Male and/or Female Subjects. Status WITHDRAWN Phase PHASE1
NCT02395133 A Study to Confirm the Efficacy and Safety of Different Dupilumab Dose Regimens in Adults With Atopic Dermatitis (AD) Status COMPLETED Phase PHASE3